Bladder cancer decisions — 2022
224 indexed Board decisions in 2022.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: GrantedPACT Act · March 2022
The Veteran's bladder cancer is granted service connection as due to exposure to herbicide agents. The appeals for peripheral neuropathy are dismissed.
- Whole decision: DeniedMarch 2022
The Board denied the claim for service connection for the cause of the Veteran's death due to bladder cancer, finding that there was no evidence linking the condition to his service, including exposure to ionizing radiation.
- Whole decision: Remanded (sent back)PACT Act · March 2022
The Board has remanded the case due to insufficient development and lack of substantial compliance with prior remand directives. The Veteran's bladder cancer is being reviewed for potential service connection based on Agent Orange exposure, but a supplemental opinion from an oncologist or physician is needed.
- Whole decision: Remanded (sent back)March 2022
The Board has remanded the cases for further development and to obtain medical opinions regarding whether the Veteran's COPD, bladder cancer, or heart condition are related to his military service. The claims will be reviewed based on the new evidence.
- Whole decision: GrantedMarch 2022
The Veteran's bladder cancer is found to be related to his in-service exposure to chemicals, specifically trichloroethylene and naptha. The Board granted service connection for the condition.
- Whole decision: Remanded (sent back)March 2022
The Veteran's bladder cancer treatment regimen included Bacillus Calmette-Guerin (BCG) immunotherapy from March 14, 2017, to August 31, 2021. The Board granted a 100 percent initial evaluation for service-connected residuals of bladder cancer from March 14, 2017, to August 31, 2021. However, the Veteran's appeal is remanded for further development regarding an initial evaluation in excess of 20 percent from September 1, 2021.
- Whole decision: DeniedFebruary 2022
The Board denied the Veteran's claim for service connection for bladder cancer, finding that his condition was not caused by in-service exposure to ionizing radiation and did not manifest during or within one year after separation from service.
- Whole decision: GrantedFebruary 2022
The Board has granted service connection for gastroesophageal reflux disease (GERD) with duodenal bulb scarring, but denied service connection for basal cell carcinoma, bladder cancer, non-Hodgkin's lymphoma, and prostate cancer due to lack of evidence linking these conditions to in-service exposure or service.
- Whole decision: GrantedFebruary 2022
The Veteran's bladder cancer is related to his exposure to herbicide agents, specifically Agent Orange. His claim for service connection has been granted.
- Whole decision: DismissedFebruary 2022
The Veteran's claim for service connection for bladder cancer was granted in a January 2022 rating decision, and the appeal is dismissed as there are no longer any disputed issues.
- Whole decision: Remanded (sent back)February 2022
The Board has remanded the issues of severance of service connection for bladder cancer and entitlement to an increased rating for bladder cancer due to incomplete development and need for further evaluation.
- Whole decision: DeniedFebruary 2022
The Veteran's claim for a total disability rating based on individual unemployability due to service-connected disabilities is denied because the combined ratings do not meet the schedular threshold and there is no evidence of unemployability.
- Whole decision: DismissedFebruary 2022
Your claim for service connection for bladder cancer has been fully granted, and you have not disagreed with this decision.
- Whole decision: GrantedFebruary 2022
The Veteran's bladder cancer is granted service connection as it was presumed to have been caused by his exposure to herbicide agents in Vietnam. His tinnitus is also granted service connection, with the presumption that it began during his active duty service. However, his bilateral hearing loss remains pending due to incomplete verification of his Reserve service periods.
- Whole decision: GrantedFebruary 2022
The Board has granted service connection for asbestosis, restrictive/obstructive lung disease, and prostate cancer. The appeal regarding bladder cancer and cerebrovascular accident (CVA) is remanded.
- Whole decision: Remanded (sent back)February 2022
The Board has remanded the claims for service connection due to a lack of compliance with previous directives, including obtaining a dose estimate from the Under Secretary for Health. The case is now referred back to the VA Under Secretary for Health and then to the VA Under Secretary for Benefits.
- Whole decision: DismissedFebruary 2022
The Veteran's claim for service connection for bladder cancer has been granted, effective May 16, 2016. The issue of service connection for rectal cancer is remanded.
- Whole decision: DeniedFebruary 2022
The Board has denied the Veteran's claim for service connection for bladder cancer, finding that there is no evidence to support a link between his current diagnosis and his military service.
- Whole decision: DismissedFebruary 2022
Your bladder cancer has already been granted service connection, so your appeal is dismissed.
- Whole decision: Remanded (sent back)February 2022
The Board has decided to remand the case due to an inadequate VA examination, and a new opinion is needed regarding whether the Veteran's bladder cancer is related to his service.
← Back to Bladder cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.